MRI Interventions Adds Wright Medical Exec to Board

Irvine, Calif.-based MRI Interventions has added industry veteran Pascal E. R. Girin to its board of directors. Girin has over two decades of management and executive experience in the field of medical technology with a proven track record of high performance in publicly traded and private equity-backed companies.

Girin has served as executive vice president and chief operating officer of Wright Medical Technology Inc. since November 2012. Prior to joining Wright Medical, Girin served in top management positions at Keystone Dental Inc., first as chief operating officer from October 2010 to February 2011, and then as CEO from February 2011 to June 2012 when the company successfully merged with Southern Implants Inc. From September 2003 to September 2010, Girin served in several executive roles at ev3 Inc., a public endovascular device company, including executive vice president and chief operating officer, in which position he was responsible for managing the company’s $500 million worldwide business. From July 2008 to January 2010, he served as ev3’s executive vice president and president, worldwide neurovascular and international, during which time he led the company’s $150 million acquisition of Chestnut Medical. During his time at ev3, Girin also served as senior vice president and president, international; and general manager, Europe. Prior to ev3, he worked in various capacities at BioScience Europe Baxter Healthcare Corporation.

Girin has additionally served on the board of directors for a number of companies, including Keystone Dental, Tornier N.V. and Mauna Kea Technologies. He received his engineering degree at the French Ecole des Mines.

“I am excited to join the board of such a groundbreaking company,” stated Girin. “I believe the company’s product platforms can vastly alter the landscape of surgical treatments for a number of neurological and cardiac disorders. I look forward to being a part of the ongoing commercialization and strategic planning surrounding these impactful technologies.”

“Pascal brings in-depth knowledge and extensive experience in medical device management to our Board of Directors,” said Kimble Jenkins, CEO of MRI Interventions. “His career has spanned all levels within medical device organizations, from managing large international divisions to running worldwide operations. We welcome him, his diverse experience and his valuable perspective to our board.”

MRI Interventions makes magnetic resonance imaging platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart.